Cerevel Therapeutics Holdings IncNASDAQ:CERE
- LAST PRICE39.7700
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots28.0000/ 3
- Ask / Lots42.6700/ 2
- Open / Previous Close0.0000 / 39.7700
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CERE |
|---|---|---|
| 09:32 ET | 10988 | 36.79 |
| 09:34 ET | 508 | 37.21 |
| 09:38 ET | 1563 | 37.3675 |
| 09:39 ET | 200 | 37.18 |
| 09:41 ET | 4799 | 37.96 |
| 09:43 ET | 1225 | 38.05 |
| 09:45 ET | 1912 | 38.12 |
| 09:48 ET | 402 | 38.22 |
| 09:50 ET | 2220 | 38.23 |
| 09:52 ET | 6620 | 38.33 |
| 09:54 ET | 1800 | 38.39 |
| 09:56 ET | 1000 | 38.4848 |
| 09:57 ET | 1708 | 38.335 |
| 09:59 ET | 850 | 38.5 |
| 10:01 ET | 11341 | 38.34 |
| 10:03 ET | 1171 | 38.14 |
| 10:06 ET | 1500 | 37.815 |
| 10:08 ET | 300 | 37.59 |
| 10:10 ET | 600 | 37.43 |
| 10:14 ET | 1207 | 37.55 |
| 10:15 ET | 307 | 37.495 |
| 10:17 ET | 7334 | 37.55 |
| 10:19 ET | 1134 | 37.68 |
| 10:21 ET | 3858 | 38 |
| 10:24 ET | 800 | 37.79 |
| 10:26 ET | 643 | 37.69 |
| 10:28 ET | 1100 | 37.9 |
| 10:30 ET | 1100 | 37.83 |
| 10:32 ET | 1235 | 37.94 |
| 10:33 ET | 2400 | 38.55 |
| 10:35 ET | 300 | 38.705 |
| 10:37 ET | 3300 | 38.5 |
| 10:39 ET | 920 | 38.51 |
| 10:42 ET | 544 | 38.445 |
| 10:44 ET | 550 | 38.33 |
| 10:46 ET | 2300 | 38.37 |
| 10:48 ET | 2692 | 38.26 |
| 10:50 ET | 1100 | 38.02 |
| 10:51 ET | 900 | 38.4379 |
| 10:53 ET | 200 | 38.38 |
| 10:55 ET | 300 | 38.27 |
| 10:57 ET | 700 | 38.375 |
| 11:00 ET | 1100 | 38.39 |
| 11:02 ET | 1112 | 38.065 |
| 11:04 ET | 500 | 38.15 |
| 11:06 ET | 300 | 37.98 |
| 11:08 ET | 500 | 38.07 |
| 11:09 ET | 867 | 37.97 |
| 11:13 ET | 3200 | 38.18 |
| 11:15 ET | 300 | 38.305 |
| 11:18 ET | 800 | 38.435 |
| 11:20 ET | 846 | 38.535 |
| 11:22 ET | 410 | 38.5 |
| 11:24 ET | 1400 | 38.315 |
| 11:27 ET | 500 | 38.345 |
| 11:29 ET | 1200 | 38.27 |
| 11:31 ET | 400 | 38.205 |
| 11:33 ET | 442 | 38.06 |
| 11:36 ET | 3000 | 38.23 |
| 11:38 ET | 1469 | 38.45 |
| 11:40 ET | 200 | 38.36 |
| 11:42 ET | 800 | 38.24 |
| 11:44 ET | 39433 | 38.78 |
| 11:45 ET | 19242 | 38.83 |
| 11:47 ET | 1827 | 38.725 |
| 11:49 ET | 1325 | 38.57 |
| 11:51 ET | 10090 | 38.555 |
| 11:54 ET | 905 | 38.49 |
| 11:56 ET | 500 | 38.28 |
| 11:58 ET | 1487 | 38.36 |
| 12:00 ET | 1292 | 38.13 |
| 12:02 ET | 200 | 38.13 |
| 12:03 ET | 800 | 38.37 |
| 12:05 ET | 1125 | 38.5 |
| 12:07 ET | 1266 | 38.515 |
| 12:09 ET | 1515 | 38.725 |
| 12:12 ET | 200 | 38.71 |
| 12:14 ET | 700 | 38.655 |
| 12:16 ET | 1937 | 38.58 |
| 12:18 ET | 3457 | 38.61 |
| 12:20 ET | 300 | 38.61 |
| 12:21 ET | 1700 | 38.58 |
| 12:23 ET | 800 | 38.5 |
| 12:25 ET | 3009 | 38.78 |
| 12:27 ET | 400 | 38.83 |
| 12:30 ET | 1300 | 38.705 |
| 12:32 ET | 100 | 38.62 |
| 12:34 ET | 200 | 38.69 |
| 12:36 ET | 300 | 38.705 |
| 12:38 ET | 5435 | 38.861 |
| 12:39 ET | 1000 | 38.705 |
| 12:41 ET | 3926 | 38.6 |
| 12:43 ET | 1700 | 38.57 |
| 12:45 ET | 3298 | 38.485 |
| 12:48 ET | 6846 | 38.535 |
| 12:50 ET | 11228 | 38.395 |
| 12:52 ET | 3346 | 38.39 |
| 12:54 ET | 2388 | 38.42 |
| 12:56 ET | 2231 | 38.42 |
| 12:57 ET | 5200 | 38.485 |
| 12:59 ET | 1488 | 38.435 |
| 01:01 ET | 900 | 38.515 |
| 01:03 ET | 6100 | 38.6 |
| 01:06 ET | 14997 | 38.53 |
| 01:08 ET | 12243 | 38.595 |
| 01:10 ET | 1000 | 38.565 |
| 01:12 ET | 1375 | 38.57 |
| 01:14 ET | 10080 | 38.565 |
| 01:15 ET | 3136 | 38.4197 |
| 01:17 ET | 1319 | 38.46 |
| 01:19 ET | 400 | 38.48 |
| 01:21 ET | 3073 | 38.56 |
| 01:24 ET | 11700 | 38.49 |
| 01:26 ET | 3140 | 38.555 |
| 01:28 ET | 1643 | 38.475 |
| 01:30 ET | 3205 | 38.525 |
| 01:32 ET | 749 | 38.56 |
| 01:33 ET | 1600 | 38.5 |
| 01:35 ET | 1153 | 38.39 |
| 01:37 ET | 1727 | 38.33 |
| 01:39 ET | 2487 | 38.2 |
| 01:42 ET | 100 | 38.235 |
| 01:44 ET | 2961 | 38.39 |
| 01:46 ET | 1780 | 38.5 |
| 01:48 ET | 900 | 38.65 |
| 01:51 ET | 100 | 38.82 |
| 01:55 ET | 1198 | 38.76 |
| 01:57 ET | 300 | 38.76 |
| 02:00 ET | 500 | 38.76 |
| 02:02 ET | 100 | 38.76 |
| 02:04 ET | 5600 | 38.7 |
| 02:06 ET | 300 | 38.645 |
| 02:08 ET | 2748 | 38.5 |
| 02:09 ET | 3139 | 38.705 |
| 02:11 ET | 400 | 38.7 |
| 02:13 ET | 6640 | 38.72 |
| 02:15 ET | 964 | 38.75 |
| 02:18 ET | 1300 | 38.86 |
| 02:20 ET | 200 | 38.88 |
| 02:22 ET | 2300 | 38.745 |
| 02:24 ET | 3160 | 38.76 |
| 02:26 ET | 100 | 38.765 |
| 02:27 ET | 300 | 38.74 |
| 02:29 ET | 1300 | 38.54 |
| 02:31 ET | 1100 | 38.5 |
| 02:33 ET | 1846 | 38.675 |
| 02:36 ET | 2100 | 38.73 |
| 02:38 ET | 600 | 38.9 |
| 02:40 ET | 1006 | 38.935 |
| 02:42 ET | 3522 | 38.91 |
| 02:44 ET | 4620 | 38.85 |
| 02:45 ET | 1745 | 39 |
| 02:47 ET | 4840 | 39 |
| 02:49 ET | 400 | 39 |
| 02:51 ET | 4471 | 39.025 |
| 02:54 ET | 5664 | 39.05 |
| 02:56 ET | 3424 | 38.77 |
| 02:58 ET | 1963 | 38.88 |
| 03:00 ET | 700 | 39.065 |
| 03:02 ET | 600 | 39.155 |
| 03:03 ET | 9305 | 39.3 |
| 03:05 ET | 3155 | 39.315 |
| 03:07 ET | 1738 | 39.375 |
| 03:09 ET | 2632 | 39.38 |
| 03:12 ET | 3590 | 39.4 |
| 03:14 ET | 600 | 39.315 |
| 03:16 ET | 1351 | 39.31 |
| 03:18 ET | 2726 | 39.375 |
| 03:20 ET | 3627 | 39.47 |
| 03:21 ET | 9800 | 39.44 |
| 03:23 ET | 7848 | 39.45 |
| 03:25 ET | 2879 | 39.48 |
| 03:27 ET | 3600 | 39.47 |
| 03:30 ET | 10115 | 39.36 |
| 03:32 ET | 1710 | 39.1551 |
| 03:34 ET | 6275 | 39.2 |
| 03:36 ET | 549 | 39.27 |
| 03:38 ET | 900 | 39.4 |
| 03:39 ET | 2600 | 39.48 |
| 03:41 ET | 7164 | 39.575 |
| 03:43 ET | 3733 | 39.705 |
| 03:45 ET | 3550 | 39.64 |
| 03:48 ET | 8747 | 39.3779 |
| 03:50 ET | 20766 | 39.48 |
| 03:52 ET | 14487 | 39.285 |
| 03:54 ET | 11465 | 39.49 |
| 03:56 ET | 18831 | 39.83 |
| 03:57 ET | 27909 | 39.81 |
| 03:59 ET | 193206 | 39.77 |
Yesterday
Aug 8, 2022
Thinking about buying stock in Bed Bath & Beyond, Kodiak Sciences, Cerevel Therapeutics, Signify Health, or Eargo?, from 8:30AM ET on Monday Aug 08, 2022 by PR Newswire
8:30AM ET on Monday Aug 08, 2022 by PR Newswire
Aug 2, 2022
--Mizuho Securities Cuts Price Target on Cerevel Therapeutics Holdings to $27 From $30, Citing Operating Expenses, Maintains Neutral Rating, from 8:41AM ET on Tuesday Aug 02, 2022 by MT Newswires
8:41AM ET on Tuesday Aug 02, 2022 by MT Newswires
Aug 1, 2022
BRIEF-Cerevel Therapeutics Reports Second Quarter 2022 Financial Results , from 7:59AM ET on Monday Aug 01, 2022 by Thomson Reuters
7:59AM ET on Monday Aug 01, 2022 by Thomson ReutersCerevel Therapeutics Q2 Net Loss Widens, from 6:27AM ET on Monday Aug 01, 2022 by MT Newswires
6:27AM ET on Monday Aug 01, 2022 by MT Newswires
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Cerevel Therapeutics Holdings Inc | 5.9B | -20.9x | --- |
Intra-Cellular Therapies Inc | 5.3B | -15.5x | --- |
Ascendis Pharma A/S | 4.8B | -11.3x | --- |
Karuna Therapeutics Inc | 6.8B | -33.6x | --- |
Cytokinetics Inc | 4.9B | -20.2x | --- |
Apellis Pharmaceuticals Inc | 7.1B | -9.5x | --- |
Company Information
Cerevel Therapeutics Holdings, Inc. is a clinical-stage biopharmaceutical company. The Company combines an understanding of disease-related biology and neurocircuitry of the brain with advanced chemistry and central nervous system (CNS) target receptor selective pharmacology to discover and design new therapies. The Company is engaged in the development of new therapies for neuroscience diseases, including schizophrenia, epilepsy and Parkinson’s disease. It is advancing diverse pipeline with numerous clinical trials underway or planned, including three ongoing Phase III trials and an open-label extension trial for tavapadon in Parkinson's, two planned Phase II trials and a planned open-label extension trial for emraclidine in schizophrenia and an ongoing Phase II proof-of-concept trial with an open-label extension trial for darigabat in focal epilepsy. Its pipeline candidates include Emraclidine, Darigabat, Darigabat and CVL-871.
Contact Information
- Headquarters
- 222 Jacobs Street, Suite 200CAMBRIDGE, MA, United States 02141
- Phone
- 212-284-2300
- Fax
- 302-636-5454
Executives
- Chairperson of the Board of Directors, Chief Executive Officer
- N. Anthony Coles
- President
- Abraham Ceesay
- Interim Chief Financial Officer, Chief Accounting Officer, Vice President - Finance
- Mark Bodenrader
- Chief Human Resources Officer
- Kenneth DiPietro
- Chief Scientific Officer
- John Renger
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $5.9B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 148.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.90 |
Book Value | $3.92 |
P/E Ratio | -20.9x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
